CORRECTED-WRAPUP 1-Top U.S. drugmakers ride new products to strong results
October 28, 2015 at 11:04 AM EDT
NEW YORK, Oct 27 (Reuters) - Growing sales of expensive new cancer drugs and other newer medicines propelled top U.S. drugmakers Pfizer Inc, Merck & Co and Bristol-Myers Squibb Co to stronger-than-expected third-quarter profits.